Heger, U., Martens, A., Schillings, L., Walter, B., Hartmann, D., Hinz, U., . . . Hackert, T. (2022). Myofibroblastic CAF density, not activated stroma index, indicates prognosis after neoadjuvant therapy of pancreatic carcinoma. Cancers, 14(16), . https://doi.org/10.3390/cancers14163881
Chicago-Zitierstil (17. Ausg.)Heger, Ulrike, et al. "Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis After Neoadjuvant Therapy of Pancreatic Carcinoma." Cancers 14, no. 16 (2022). https://doi.org/10.3390/cancers14163881.
MLA-Zitierstil (9. Ausg.)Heger, Ulrike, et al. "Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis After Neoadjuvant Therapy of Pancreatic Carcinoma." Cancers, vol. 14, no. 16, 2022, https://doi.org/10.3390/cancers14163881.